pbenusiglio.bsky.social
@pbenusiglio.bsky.social
🚨#CDH1 alert! Our latest study supports the safety of endoscopic surveillance in asymptomatic CDH1 PV carriers, confirming that recent scientific advances can be successfully applied in a real-world clinical setting 👨🏼‍⚕️. jmg.bmj.com/content/earl...
Expert endoscopic surveillance in CDH1 pathogenic variant carriers seems safe, even after positive (pT1a) biopsies
Surveillance is increasingly considered an alternative to prophylactic total gastrectomy in asymptomatic carriers of CDH1 pathogenic variants. There are three main reasons for this paradigm shift: (1)...
jmg.bmj.com
November 21, 2025 at 4:54 PM
The INSERM-Sorbonne #PrediLynch dream team! #HorizonEU
@glimmerfhu.bsky.social
June 19, 2025 at 7:50 AM
In our study of 268 #colorectalcancer patients < age 41, prevalence of pathogenic germline variants varied dramatically by phenotype.
Unless you have unlimited resources, testing decisions should be phenotype-driven!
rdcu.be/edTa5 or www.nature.com/articles/s41...
#LynchSyndrome #ejhg
Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotype
European Journal of Human Genetics - Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotype
rdcu.be
March 26, 2025 at 1:31 PM